TrianglePUBLICATIONS · 28644774
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2017 Aug 10
- First author
- Lamba JK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Lamba JK
- type
- Author
- name
- Chauhan L
- type
- Author
- name
- Shin M
- type
- Author
- name
- Loken MR
- type
- Author
- name
- Pollard JA
- type
- Author
- name
- Wang YC
- type
- Author
- name
- Ries RE
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Walter RB
- type
- Author
- name
- Bernstein ID
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lamba JK
- type
- Author
- name
- Chauhan L
- type
- Author
- name
- Shin M
- type
- Author
- name
- Loken MR
- type
- Author
- name
- Pollard JA
- type
- Author
- name
- Wang YC
- type
- Author
- name
- Ries RE
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Walter RB
- type
- Author
- name
- Bernstein ID
- type
- Author
- bibliography ids
- nci-bib-84cf84d7b28c953cedd016cb
- book metadata
- content sha256
- 6b631dfcdbe7e7c6c5ad9a1407efb0d2a084b3543765b2b87cf4e6d676ddd685
- document type
- citation
- dois
- 10.1200/JCO.2016.71.2513
- electronic publication date
- display
- 2017 Jun 23
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28644774
- immutable id
- pubmed:28644774@6b631dfcdbe7e7c6c5ad9a1407efb0d2a084b3543765b2b87cf4e6d676ddd685
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 23
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2674-2682
- volume
- 35
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28644774
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 3bb91ff6add51f1048706b9e76acc7d5ec96b74c14767ec3292e596d251d6866
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Aug 10
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.
Preserved source evidence · Not medical advice